BamSEC and AlphaSense Join Forces
Learn More

Rapport Therapeutics Inc. – Indentures

NASDAQ: RAPP    
Share price (11/4/26): $25.93    
Market cap (11/4/26): $1.534 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.3
from 8-K 123 pages Rapport Therapeutics, Inc. and U.S. Bank Trust Company, National Association, as Trustee First Supplemental Indenture Dated as of October 30, 2026 2.25% Convertible Senior Notes Due 2032
12/34/56
EX-4.2
from 8-K 55 pages Rapport Therapeutics, Inc., Issuer and U.S. Bank Trust Company, National Association, Trustee Indenture Dated as of October 30, 2026 Senior Debt Securities
12/34/56
EX-4.1
from 8-K 16 pages Form of Pre-Funded Warrant to Purchase Common Stock Rapport Therapeutics, Inc
12/34/56
EX-4.8
from S-3ASR 41 pages Rapport Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities
12/34/56
EX-4.7
from S-3ASR 40 pages Rapport Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities
12/34/56
EX-4.6
from S-3 41 pages Rapport Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Subordinated Debt Securities
12/34/56
EX-4.5
from S-3 40 pages Rapport Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 202[•] Senior Debt Securities
12/34/56
EX-4.3
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as Amended
12/34/56
EX-4.2
from S-1 32 pages Rapport Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement August 7, 2023
12/34/56
EX-4.1
from S-1 2 pages Indenture or similar
12/34/56
EX-4.2
from DRS 32 pages Rapport Therapeutics, Inc. Amended and Restated Investors’ Rights Agreement August 7, 2023
12/34/56